Point72 Hong Kong LTD Sarepta Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $765,657 - $1.11 Million	6,756 New	6,756 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $280,548 - $519,999	4,168 New	4,168 $401,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $305,414 - $481,014	4,034 Added 40.49%	13,996 $1.55 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $238,723 - $336,779	3,808 Added 61.88%	9,962 $747,000
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $148,970 - $213,300	2,359 Added 62.16%	6,154 $481,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $286,554 - $368,649	-3,708 Reduced 49.42%	3,795 $342,000
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $494,972 - $693,877	7,503 New	7,503 $694,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $2.22 Million - $3.16 Million	-17,696 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $1.92 Million - $2.6 Million	15,094 Added 580.09%	17,696 $2.49 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $241,986 - $446,763	2,602 New	2,602 $417,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $180,840 - $320,375	-2,363 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $172,050 - $370,778	2,363 New	2,363 $178,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $960 - $1,365	-9 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $875 - $1,338	9 New	9 $1,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.